| Miss Janvi Bhadra, MPT | |
|
3911 W Clara Ln, Muncie, IN 47304-5412 | |
| (765) 587-0241 | |
| (765) 245-9833 |
| Full Name | Miss Janvi Bhadra |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 3911 W Clara Ln, Muncie, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588373633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 05012717A (Indiana) | Secondary |
| 225100000X | Physical Therapist | 05012717A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Janvi Bhadra, MPT 2122 York Rd Ste 300, Oak Brook, IL 60523-1925 Ph: (630) 575-1980 | Miss Janvi Bhadra, MPT 3911 W Clara Ln, Muncie, IN 47304-5412 Ph: (765) 587-0241 |
News Archive
Navidea Biopharmaceuticals, Inc., a specialty pharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Phase 3 clinical study investigating 99m-Tc-Tilmanocept in oral and squamous cell cancers (SCC) were presented as a poster presentation at the 65th Annual Cancer Symposium of the Society of Surgical Oncology (SSO) meeting held in Orlando, Florida, March 21-24, 2012.
The U.S. Department of Treasury released proposed regulations Monday that would ban debt collection activities in the emergency rooms of non-profit hospitals. The proposed restriction comes in the wake of a lawsuit by Minnesota's attorney general alleging Fairview Health Systems former contractor, Accretive Health hit up patients in emergency rooms for payment before treatment. The Treasury Department has proposed adding regulations to a part of the federal health care law to protect patients from abusive collection practices.
Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.
Female mouse fetuses exposed to very high doses of a common industrial chemical that makes plastics more pliable develop significant reproductive alterations and precancerous lesions as they grow up, according to a new toxicology study conducted at Brown University.
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded on January 20th the first $61 million in grants for cancer research projects at academic institutions and private companies throughout Texas. These are the inaugural grants of the $3 billion to be invested in cancer research in Texas over the next ten years.
› Verified 9 days ago